Latest News in the pharma Industry

Biopharma News

Flixabi, Biogen’s infliximab biosimilar referencing Remicade, approved in the EU

Flixabi, Biogen’s infliximab biosimilar referencing Remicade, approved in the EU

30 May 2016

Biogen to manufacture and commercialize Flixabi, the company’s second anti-TNF biosimilar therapy in the EU.

Read more 
BioPharma Services USA awarded a 5 Year, $20 million contract with the FDA

BioPharma Services USA awarded a 5 Year, $20 million contract with the FDA

22 May 2016

The contract is to conduct in vivo studies of generic drug products in human subjects from 2016 through to 2021.

Read more 
BMS opens expanded biologics facility

BMS opens expanded biologics facility

17 May 2016

$280 million project increases workforce, adds new capabilities

Read more 
AstraZeneca announces positive results from benralizumab Phase III programme in severe asthma

AstraZeneca announces positive results from benralizumab Phase III programme in severe asthma

17 May 2016

Benralizumab first AstraZeneca respiratory biologic to complete Phase III.

Read more 
Fujifilm Diosynth Biotechnologies opens new laboratory facility in Research Triangle Park, NC

Fujifilm Diosynth Biotechnologies opens new laboratory facility in Research Triangle Park, NC

12 May 2016

Construction now complete on new 62,000 square foot facility.

Read more 
JHL Biotech opens innovative biosimilars manufacturing facility in China

JHL Biotech opens innovative biosimilars manufacturing facility in China

10 May 2016

GE Healthcare delivers world’s first modular manufacturing solution based on single-use bioprocessing technology in just 18 months.

Read more 
FDA grants Priority Review for Lilly's olaratumab, an investigational medicine for advanced soft tissue sarcoma

FDA grants Priority Review for Lilly's olaratumab, an investigational medicine for advanced soft tissue sarcoma

8 May 2016

Lilly has received additional designations for olaratumab from the FDA, including Breakthrough Therapy, Fast Track and Orphan Drug, for this indication.

Read more 
Alnylam breaks ground on new manufacturing facility in Norton, Massachusetts

Alnylam breaks ground on new manufacturing facility in Norton, Massachusetts

1 May 2016

200,000 sq ft state-of-the-art biopharmaceutical manufacturing facility supports expanding development pipeline and transition toward commercial stage.

Read more 
Merck introduces first multi-use disposable sterile connectors for biopharma

Merck introduces first multi-use disposable sterile connectors for biopharma

29 Apr 2016

New Lynx CDR connectors facilitate faster and more economic biopharma fluid management.

Read more 
Pall Life Sciences launches commercial Cadence Acoustic Separator for intensified bioprocess clarification and purification applications

Pall Life Sciences launches commercial Cadence Acoustic Separator for intensified bioprocess clarification and purification applications

27 Apr 2016

The commercial launch of the CAS is the first in a series of product launches that enable continuous bioprocessing.

Read more 
Eppendorf Centrifuge 5920 R: the new benchmark in capacity and performance

Eppendorf Centrifuge 5920 R: the new benchmark in capacity and performance

27 Apr 2016

Also offers a powerful state-of-the-art refrigeration system with advanced temperature management.

Read more 
SGS introduces new bio-layer interferometry analysis for biopharmaceutical development

SGS introduces new bio-layer interferometry analysis for biopharmaceutical development

26 Apr 2016

This new service offers a number of advantages compared with current analytical techniques.

Read more